Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
INTERNATIONAL JOURNAL OF OBESITY, vol.31, no.7, pp.1119-1125, 2007 (Journal Indexed in SCI)
Article / Article
Title of Journal :
INTERNATIONAL JOURNAL OF OBESITY
Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.